Diabetes Board decisions

The Board has remanded the claims for diabetes mellitus and hypertension secondary to service-connected PTSD due to inadequate opinions regarding aggravation.

The Board has remanded the claims for diabetes mellitus, Type II; an acquired psychiatric disorder (to include anxiety and insomnia); alopecia; tension headaches; and hypertension due to deficiencies in VA's duty to assist and inadequate examinations.

The Veteran's DMII and hypertension were granted service connection due to in-service herbicide agent exposure.,Her glaucoma, sleep apnea, lung condition (including COPD and asthma), GERD, breast cancer, IBS, endocrinopathy, hypothyroidism, tinnitus, blood clots, heart condition, and bilateral hearing loss were all remanded for further development due to insufficient evidence.

The Board denied service connection for diabetes mellitus, type II as there is no current diagnosis of the condition.

The Board denied the reopening of claims for service connection for diabetes mellitus, poor eyesight (claimed as secondary to diabetes mellitus), erectile dysfunction (claimed as secondary to a service-connected condition), hypertension, and kidney damage (secondary to hepatitis C).

The Board has denied service connection for diabetes mellitus and remanded the cases of hepatitis C, erectile dysfunction, PTSD, and tinnitus due to insufficient evidence.

The Veteran's PTSD is rated at 100 percent, and he has additional service-connected disabilities independently ratable at 60 percent or more. Therefore, the Veteran is granted a total disability rating based on individual unemployability (TDIU) and special monthly compensation (SMC) at the housebound rate.

The Veteran's asthma and allergic rhinitis have been granted service connection on a presumptive basis due to toxic exposure in the Southwest Asia Theater of operations during the Gulf War.,Diabetes mellitus type II, diabetic neuropathy, bilateral hearing loss, tinnitus, and chronic back pain are all remanded for further review.

The Board has denied the Veteran's claims for service connection for a heart disorder and diabetes mellitus, finding no evidence of herbicide exposure during service that would support presumptive service connection.

The Veteran's claims for increased ratings for ED and DM II have been denied. The Board found that the evidence did not meet the criteria for a compensable rating for ED or a higher than 20 percent rating for DM II.

The Veteran's claims for service connection are being remanded due to inadequate medical opinions and the need for additional evidence, including VA examinations.

The Board has granted earlier effective dates for the grant of service connection for diabetes mellitus and ischemic heart disease. The issues of an increased rating for ischemic heart disease and TDIU are remanded to allow for appropriate development.

The Veteran's service connection claims for diabetes mellitus type II, erectile dysfunction secondary to diabetes mellitus type II, right lower extremity peripheral neuropathy as secondary to diabetes mellitus type II, and left lower extremity peripheral neuropathy as secondary to diabetes mellitus type II have been granted. The Board has also remanded the Veteran's service connection claims for bilateral lower extremity vascular disease as secondary to diabetes mellitus type II.

The Veteran's hypertension is granted under the PACT Act, effective from August 10, 2022. The claim for an increased rating of diabetes mellitus type II remains pending and will be remanded.

The Board has remanded the Veteran's claims for service connection due to inadequate opinions and missing information. The claims are now pending again with new instructions for obtaining more specific medical opinions.

The Board has granted service connection for hypertension, type II diabetes mellitus, and diabetic peripheral neuropathy of the upper and lower extremities as secondary to the Veteran's service-connected obstructive sleep apnea and depression.

The Board has decided to remand the case due to insufficient medical evidence regarding whether the Veteran's service-connected conditions contributed substantially or materially to his death. The claim is being returned for a VA medical opinion.

The Veteran's claim for service connection for diabetes mellitus type II (DM II) was withdrawn. The Board granted the Veteran's claim for seizures, finding that reasonable doubt in favor of the Veteran's claim has been resolved.,Service connection is denied for chloracne as there is no evidence of current disability and the Veteran did not have chloracne during service or within one year after separation from service. Service connection for osteoporosis of the left hip and right hip, and peripheral neuropathy of the lower extremities are also denied due to lack of in-service onset.

The Board has dismissed the claims for increased disability ratings for left lower extremity peripheral neuropathy, right lower extremity peripheral neuropathy, right upper extremity neuropathy, and diabetes mellitus type II. The claim for an increased disability rating for left upper extremity neuropathy was not addressed in this decision.

The Veteran's TDIU and SMC benefits are granted effective July 30, 2021. DEA eligibility is also granted on the same date.